High rate of seromarkers for HIV, HBV and syphilis among blood donors using confidential unit exclusion, before and after HIV-NAT implementation at a major public blood bank in the Brazilian Amazon.

Abstract

BACKGROUND:

Confidential unit exclusion (CUE) was introduced in the 1980's as an additional layer to blood safety, before highly specific and sensitive nucleic acid tests (NAT) for HIV were implemented. The utility of CUE-use in settings that have implemented NAT should be evaluated over time.

STUDY DESIGN, METHODS:

Cross-sectional retrospective study carried out from June 2010-November 2015, at Manaus Hemocenter (HEMOAM), Amazonas, Brazil that implemented HIV-NAT in 2012. The HIV, HCV, HBV, HTLV, Chagas disease, and syphilis rates were compared among CUE and non-CUE blood donors, before and after HIV-NAT implementation.

RESULTS:

Among 287,588 donations, 2,154 (0.75%) were associated with CUE, mainly voluntary donations (64.2%), by repeat donors (58.4%) from young (median age = 31 years), males (84.4%), unmarried (63.1%). CUE-users compared to non-CUE donors (n = 285,434) had higher seropositivity rates to HIV (OR = 6.09, 95% CI: 3.68-10.07, p < 0.001), HBV (anti-HBc OR = 1.81 95% CI: 1.24-2.64, p = 0.004; HBsAg OR = 5.68, 95% CI: 1.78-18.07, p = 0.017), and syphilis (OR = 1.78, 95% CI: 1.05-3.04, p = 0.030). Most (97.2%) discarded blood units associated to CUE was seronegative for all pathogens. Most donations (73.4%) were tested by HIV-NAT and showed four window period donations, positive by HIV-NAT only among non-CUE donors.

CONCLUSION:

A high rate of transfusion transmissible infections/TTIs was observed at HEMOAM especially in CUE-users. CUE-use offered an additional layer of blood safety by its association with anti-HBc/HBsAg and syphilis that are not covered by NAT. For blood banks in highly endemic areas for HIV and TTI, as HEMOAM, the identification of at risk donors, and the orientation to be tested at proper sites remain a great challenge.

• Authors: Janaina C Souza, Myuki A E Crispim, Claudia Abrahim, Nelson A Fraiji, Dagmar Kiesslich, Mariane M A Stefani
• Journal: Transfusion (Transfusion) Vol. 59 Issue 2 Pg. 629-638 (02 2019) ISSN: 1537-2995 [Electronic] United States
• PMID: 30499594 (Publication Type: Clinical Trial, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
• Copyright: © 2018 AABB.

Chemical References

• Biomarkers
• DNA, Bacterial
• DNA, Viral
• Hepatitis B Antibodies

Topics

• Adolescent
• Adult
• Biomarkers (blood)
• Blood Safety
• Brazil (epidemiology)
• Child
• DNA, Bacterial (blood)
• DNA, Viral (blood)
• Female
• HIV Infections (blood, epidemiology)
• HIV-1
• Hepatitis B
• Hepatitis B Antibodies (blood)
• Humans
• Male
• Middle Aged
• Nucleic Acid Amplification Techniques
• Retrospective Studies
• Syphilis (blood, epidemiology)
• Transfusion Reaction (blood, epidemiology)